{
  "pmcid": "6326436",
  "sha256": "93a030a51b9908f6998bde2e16e37931760846e379597d61f516c26652c42143",
  "timestamp_utc": "2025-11-09T16:08:17.458358+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.053263157894737,
    "reading_ease": 34.56478947368424,
    "word_count": 200
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 1,
        "evidence": "distal segments of radial arteries obtained by no-touch technique from coronary artery bypass graft (CABG) patients (n=10)"
      },
      "Intervention": {
        "score": 2,
        "evidence": "compare the efficacy of two different papaverine concentrations (0.5 mg/ml and 2 mg/ml)"
      },
      "Objective": {
        "score": 1,
        "evidence": "The aim of this study was to compare the efficacy of two different papaverine concentrations (0.5 mg/ml and 2 mg/ml) for vasospasm prevention and their impact on endothelium integrity."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The vasodilatory effect of papaverine (concentrations of 0.5 mg/ml and 2 mg/ml) was assessed in vitro"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "2 mg/ml papaverine concentration showed stronger vasodilatatory effect than 0.5 mg/ml, but it caused significantly higher endothelial damage."
      },
      "Harms": {
        "score": 1,
        "evidence": "it caused significantly higher endothelial damage"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 8,
    "max_score": 25
  }
}